Chemotherapy-associated cardiomyopathyDisease1 paperHumans1LatestRedox Biology·10 FebFNDC5/irisin mitigates the cardiotoxic impacts of cancer chemotherapeutics by modulating ROS-dependent and -independent mechanismsStudy in peopleOxidative stress and ROS signallingPaper
Redox Biology·10 FebFNDC5/irisin mitigates the cardiotoxic impacts of cancer chemotherapeutics by modulating ROS-dependent and -independent mechanismsStudy in peopleOxidative stress and ROS signallingPaper